BioBond Continues to Grow Its IP Portfolio to Commercialize Sustainable Adhesives and Coating Solutions LAFAYETTE, INDIANA / ...

BioBond Continues to Grow Its IP Portfolio to Commercialize Sustainable Adhesives and Coating Solutions LAFAYETTE, INDIANA / ...

McKinsey & Company Inc., a management consulting firm, recently agreed to pay $650 million to resolve a civil and criminal investigation into consulting work performed by the firm with opioids ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

A federal judge extended a pause protecting the Sackler family, owners of Purdue Pharma LP, from opioid lawsuits to give the OxyContin maker, states and victims representatives time to finalize a new ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...